Concepedia

Xingyuan Xu

XX

Statistics

Publications

9

Citations

660

H-Index

9

Active since

2015

Affiliations

Zhejiang University(Current)

First Affiliated Hospital Zhejiang University

Second Affiliated Hospital of Zhejiang University

Xingyuan Xu is an author at Zhejiang University specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2015–2024

9

Publications

9

Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis

Long‐Yun Ye, Wei Chen, Xueli Bai et al. · Cancer Research · 2016 · 272 citations

, , +17

Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells

Kangning Zhang, Xingyuan Xu, Muhammad Asghar Pasha et al. · The Journal of Immunology · 2017 · 139 citations · Full text

, , +17

Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression

Xingyuan Xu, Long‐Yun Ye, Qi Zhang et al. · Hepatology · 2021 · 95 citations · Full text

, , +17

Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC).

Qi Zhang, Qihan Fu, Wanyue Cao et al. · Journal of Clinical Oncology · 2024 · 48 citations

, , +17

B7‐H5/<scp>CD</scp>28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma

Qi Chen, Jianxin Wang, Wei Chen et al. · Cancer Science · 2018 · 32 citations · Full text

, , +17

1–5 of 9